The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Biocept, Inc. (BIOC) one of those stocks right now? A quick ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

We feel now is a pretty good time to analyse Biocept, Inc.'s (NASDAQ:BIOC) business as it appears the company may be on the cusp of a considerable accomplishment. Biocept, Inc., a molecular oncology ...

A week ago, Biocept, Inc. (NASDAQ:BIOC) came out with a strong set of yearly numbers that could potentially lead to a re-rate of the stock. The results were impressive, with revenues of US$27m ...